Mitral Atresia Overview

Save information for later
Sign Up

Learn About Mitral Atresia

What is the definition of Mitral Atresia?
Mitral valve atresia is a rare congenital (present at birth) defect of the heart’s mitral valve. The mitral valve connects the heart’s left atrium (upper chamber) and left ventricle (lower chamber). In mitral valve atresia blood from the left atrium does not flow to the left ventricle, causing the left ventricle to become underdeveloped, while the body's blood is not properly oxygenated. Mitral valve atresia is often associated with other congenital heart defects, such as transposition of the great arteries, patent ductus arteriosus, and coarctation of the aorta, among others.
What are the symptoms of Mitral Atresia?
Symptoms of mitral valve atresia depend on its severity and any associated congenital heart defects and may include difficulty breathing; rapid breathing; bluish or gray skin, lips, or nails (cyanosis); pale, cool, or clammy skin; poor peripheral pulses; rapid heart rate; failure to thrive; and congestive heart failure.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Mitral Atresia?
Treatment for mitral valve atresia may include oxygen, mechanical ventilation, diuretics, vasopressors, antibiotics, shunts, and staged corrective surgeries.
Who are the top Mitral Atresia Local Doctors?
Advanced in Mitral Atresia
Dr. James P. Strainic
Pediatric Cardiology | Pediatrics
Advanced in Mitral Atresia
Dr. James P. Strainic
Pediatric Cardiology | Pediatrics

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
Languages Spoken:
English
See accepted insurances
Accepting New Patients

James Strainic is a Pediatric Cardiologist and a Pediatrics provider in Cleveland, Ohio. Dr. Strainic is rated as an Advanced provider by MediFind in the treatment of Mitral Atresia. His top areas of expertise are Pulmonary Atresia, Pulmonary Atresia with Intact Ventricular Septum, Ventricular Septal Defects, and Congenital Coronary Artery Malformation. Dr. Strainic is currently accepting new patients.

Advanced in Mitral Atresia
Dr. Michael J. Farias
Pediatric Cardiology | Cardiology | Pediatrics
Advanced in Mitral Atresia
Dr. Michael J. Farias
Pediatric Cardiology | Cardiology | Pediatrics

Boston Childrens Heart Foundation Inc

300 Longwood Ave, 
Boston, MA 
617-355-6000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Farias is a Pediatric Cardiologist and a Cardiologist in Boston, Massachusetts. Dr. Farias is rated as an Advanced provider by MediFind in the treatment of Mitral Atresia. His top areas of expertise are Patent Ductus Arteriosus, Hypoplastic Left Heart Syndrome (HLHS), Pulmonary Artery Agenesis, Osteotomy, and Spinal Fusion. Dr. Farias is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Mitral Atresia
Dr. Matthew R. Carazo
Cardiology
Advanced in Mitral Atresia
Dr. Matthew R. Carazo
Cardiology

Regents Of The University Of California

200 W Arbor Dr, 
San Diego, CA 
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Carazo is a Cardiologist in San Diego, California. Dr. Carazo has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Mitral Atresia. His top areas of expertise are Congenital Heart Disease (CHD), Transposition of the Great Arteries, Pulmonary Valves Agenesis, Anomalous Left Coronary Artery from the Pulmonary Artery, and Heart Transplant. Dr. Carazo is currently accepting new patients.

View All Doctors
What are the latest Mitral Atresia Clinical Trials?
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.
Who is this study for: Patients with Hypoplastic Left Heart Syndrome, Congential Heart Defects
Enrollment Status: Recruiting
Publish Date: June 27, 2025
Intervention Type: Combination product
Study Drug: Tissue Engineered Vascular Grafts
Study Phase: Phase 2

Summary: A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials